Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Biosynthetic Technologies has raised $9.5 million in a first round of funding to commercialize its Estolides line of biobased synthetic oils for use in lubricants, chemicals, and cosmetics. Early-stage venture investor HG Ventures led the round. Biosynthetic Technologies is providing samples of its products to clients from a pilot facility. The Indianapolis-based company says the oils, which are made from plant fatty acids, are higher performing than petroleum versions, biodegradable, and nontoxic.
This article has been sent to the following recipient: